Back to Screener

Healthcare

Bumrungrad Hospital Public Company Limited(BUGDF)

Live Price

Offline

$4.75

+0.00% today

1Y Change

-24.72%

Window

Jun 26, 2025 โ†’ Jun 22, 2026

Market Cap
$142.30B
Revenue Growth
-2.3%
EPS Growth
-3.3%
Dividend Yield
6.1%

Coverage: 247 bars ยท Jun 26, 2025 โ†’ Jun 22, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Bumrungrad Hospital Public Company Limited (BUGDF) is a Healthcare stock with a market cap of $142.30B. The stock last traded around $4.75 and down 24.7% across the available one-year price window (Jun 26, 2025 โ†’ Jun 22, 2026). Baseline metrics include revenue growth of -2.3%, EPS growth of -3.3%, a dividend yield of 6.1%. What stands out right now is revenue -2.3%, EPS -3.3%, free cash flow -10.3% with operating margin 34.9% and ROIC 20.9%. The dividend matters to the case here, with a current yield around 6.1%. Valuation sits in the middle of the pack at P/E 18.8 and price/sales 5.6. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines BUGDF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

BUGDF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BUGDF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BUGDF Max Drawdown

-32.96%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BUGDF and SPY.

Calendar-year return history is still loading or unavailable.

Unable to load analyst forecasts.

Timed out loading forecasts for BUGDF

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.